Skip to main content

Table 1 Baseline characteristics of 234 HIV-1 infected naïve patients, Dar es Salaam, 2010

From: Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania

Characteristics Females (N = 164) Males (N = 70) P Value
Categorical Variables N (%) N (%)
Primary level education 156 (95.1) 59 (84.3) 0.005
Above 100 US Dollar monthly income 57 (34.8) 43 (61.4) 0.0002
Having relative to remind to take medication 133 (81.1) 59 (84.3) 0.95
Alcohol Intake 33 (20.1) 18 (25.7) 0.4
Use of traditional medicine 97 (59.2) 45 (65.2) 0.5
History of Intravenous Drug abuse 8 (4.9) 7 (10) 0.2
Knowledge on ARV use and side effects 10 (6.9) 14 (20) 0.005
HIV testing due to Chronic illness 105 (64) 55 (78.6) 0.04
Starting treatment within one year of HIV diagnosis 130 (79.3) 55 (78.6) 0.96
Presence of 2 or more opportunistic infections 75 (45.7) 37 (52.9) 0.3
WHO Staging at initiation of therapy   
Stage I 16 (9.8) 5 (7.1) 0.6
Stage II 49 (29.9) 16 (22.9) 0.3
Stage III 82 (50.0) 34 (48.6) 0.8
Stage IV 17 (10.4) 15 (21.4) 0.04
CD4 < 100 cells/μl at ART initiation 50 (33.3)* 31 (47.0)* 0.05
Continuous variables Median (IQR) Median (IQR) P Value
Age (Years) 35 (30.5-43.5) 37 (33.5-42.0) 0.38
CD4 (cells/μl) at ART initiation 149 (6-148; 75-218) 102 (3-221; 47-184) 0.02
Continuous Variables Mean (SD) Mean (SD) P Value
BMI at initiation of therapy 22 (5) 20 (4) 0.002
Log10 Viral Load (RNA copies/ml) at initiation of therapy 5.1 (1.3) 5.5 (1.1) 0.05
  1. Legend:
  2. *Data missing for females [14 (8.5%)] and males [4 (5.7%)].